focus -WSS

focus

author：explore 2025-10-01 00:06:38 - browse：8647

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Having children helps parents live longer, especially after age 80

focus

entertainment

WSS

Ebola vaccine can save some who are already sick, per new study

Obamacare plans could cover weight loss drugs

Abridge raises $150m as clinical notes automation market heats up

Why Eli Lilly’s earnings didn’t quite live up to the hype

ACIP vaccine advisory panel sees its vacancies filled

WATCH: Why do our ears pop?

Wikipedia

focus

knowledge

Drug repurposing or repositioning? The language matters

Congress may force more Covid

How one medical school became remarkably diverse

FDA warns medical device makers about rise in fabricated data

Apple is now the first public company to be valued at $3 trillion

Having children helps parents live longer, especially after age 80

At least 13 dead in Texas as scorching temps continue

As AI regulations shape up, health tech startups beg for clarity

In Memoriam: Notable people who died in 2023

New study raises questions about niacin and heart health

hotspot

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

WATCH: Why do our ears pop?

Congress might make insulin pumps more accessible to the blind

Too many hospitalized Covid

In 'major milestone,' FDA approves first cell therapy for solid tumors

Obamacare plans could cover weight loss drugs

explore

focus

entertainment

hotspot